Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CLDN9 |
| Upstream (Parents) |
|---|
| (<<) FES → CLDN9 |
| (<<) AMIGO2 → CLDN9 |
| (<<) HBEGF → CLDN9 |
| (<<) MTMR11 → CLDN9 |
| (<<) PDYN → CLDN9 |
| Downstream (Children) |
|---|
| CLDN9 → ADAM3B (>>) |
| CLDN9 → DMC1 (>>) |
| CLDN9 → PSMD9 (>>) |
| CLDN9 → GABRA1 (>>) |
| CLDN9 → IL1RAPL1 (>>) |
| CLDN9 → TFAP4 (>>) |
